As The Stock Rises By 1.71% Year-To-Date, Enlivex Therapeutics Ltd (NASDAQ: ENLV)’S Stock Continues To Progress In 2025
During the last session, Enlivex Therapeutics Ltd (NASDAQ:ENLV)’s traded shares were 0.39 million, with the beta value of the company hitting 0.78. At the end